In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer
Authors:
- S. BarniSBS. Barni
- F. RovelliFRF. Rovelli
- S. PittalisSPS. Pittalis
- A. ArdizzoiaAAA. Ardizzoia
- G. TanciniGTG. Tancini
- E. TisiETE. Tisi
- R. RescaldaniRRR. Rescaldani
- L. VigoréLVL. Vigoré
- A. BiondiABA. Biondi
- 1 January 1993
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 29 (8) , 1127-1132
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alphaEuropean Journal of Cancer, 1992
- Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2European Journal of Cancer and Clinical Oncology, 1991
- Human Monocytes in a Long-Term Culture with Interleukin-2 Show High Tumoricidal Activity Against Various Tumor CellsJournal of Immunotherapy, 1991
- Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantationBritish Journal of Haematology, 1991
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Interleukin‐1 and Glucocorticoid Hormones Integrate an Immunoregulatory Feedback CircuitaAnnals of the New York Academy of Sciences, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitroJournal of Clinical Immunology, 1986
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.Journal of Experimental Medicine, 1982